Facilitating patient self-management in chronic disease: integrating electronic personal health records and ongoing communication into a web-based self-management tool

Facilitating patient self-management in chronic disease: integrating electronic personal health records and ongoing communication into a web-based self-management tool - a multicentre, two-armed randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN34326236

Enrollment

Registered

2009-04-07

Start date

2009-03-30

Completion date

Unknown

Last updated

2016-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Respiratory Asthma

Interventions

Intervention group: access to the web-based self-management tool including personal asthma profile, educational material, communication and feedback with the healthcare team, telephone follow-up by th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male and female patients over the age of 18 years suffering from asthma 2. Have full health insurance coverage from Régie de l'assurance maladie du Québec (RAMQ) 3. Physicians are actively using the asthma decision support system 4. In poor control despite being prescribed appropriate therapy and a written action plan. Specifically, poor control is defined as those patients who have had a respiratory-related emergency room (ER) visit or excessive beta-2-agonist use in the six months before recruitment.

Exclusion criteria

Exclusion criteria: 1. Aged over 60 years 2. Serious medical diagnosis such as lung cancer 3. Severely limited mobility preventing patients from leaving home

Design outcomes

Primary

Measure	Time frame
1. Asthma Specific Health-Related Quality of Life, measures four functional impairments at baseline and at the end of the study 2. Asthma control, defined as the excess use of rescue fast-acting bronchodilators (beta-2-agonists) (FABA) at baseline and at the end of the study	—

Secondary

Measure	Time frame
1. Technology Acceptance Measure (TAM): to evaluate intention to use the system and perceived benefits at the end of the study 2. Usage rates of the system, assessed by examining automated audit trails which will include the frequency of use defined as the number of minutes patients spent logged into the system/week 3. Patterns usage 4. Asthma Self-Efficacy, using a rating scale an overall mean score is calculated that can range from 1 (no confidence) to 5 (very confident), measured at baseline and at the end of the study 5. Medication adherence, evaluated by comparing medications prescribed to medications dispensed based on the prescription claims file 6. Healthcare utilisation: asthma-related emergency room (ER) visits/hospitalisations	—

Measure

Time frame

1. Technology Acceptance Measure (TAM): to evaluate intention to use the system and perceived benefits at the end of the study 2. Usage rates of the system, assessed by examining automated audit trails which will include the frequency of use defined as the number of minutes patients spent logged into the system/week 3. Patterns usage 4. Asthma Self-Efficacy, using a rating scale an overall mean score is calculated that can range from 1 (no confidence) to 5 (very confident), measured at baseline and at the end of the study 5. Medication adherence, evaluated by comparing medications prescribed to medications dispensed based on the prescription claims file 6. Healthcare utilisation: asthma-related emergency room (ER) visits/hospitalisations

—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 27, 2026